PUT/NOVO-NORDISK B/1500/0.1/21.06.24 | Market Closed - BOERSE MUENCHEN 19:25:22 17/05/2024 BST | ||
| 8.02 EUR | +1.39% |
|
| Current month | +0.38% | ||
| 1 month | -4.86% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 8.02 | +1.39% |
| 16/05/24 | 7.91 | +0.38% |
| 15/05/24 | 7.88 | -1.01% |
| 14/05/24 | 7.96 | -0.38% |
| 13/05/24 | 7.99 | -3.15% |
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 07:25 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | Goldman Sachs |
| WKN | GQ4V3X |
| ISIN | DE000GQ4V3X4 |
| Date issued | 13/09/2023 |
| Strike | 1,500 kr |
| Maturity | 21/06/2024 (35 Days) |
| Parity | 10 : 1 |
| Emission price | 10.97 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.81 € |
|---|---|
| Lowest since issue | 7.77 € |
| Spread | 0.1 € |
| Spread % | 1.23% |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
903.3
DKK
Average target price
909.2
DKK
Spread / Average Target
+0.66%
- Stock Market
- Warrants
- Warrant
